| Machine learning-based analysis of [18F]DCFPyL PET radiomics for risk stratification in primary prostate cancer MCF Cysouw, BHE Jansen, T van de Brug, DE Oprea-Lager, E Pfaehler, ... European journal of nuclear medicine and molecular imaging 48, 340-349, 2021 | 110 | 2021 |
| Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial - BHE Jansen, YJL Bodar, GJC Zwezerijnen, D Meijer, JP Van Der Voorn, ... European journal of nuclear medicine and molecular imaging 48, 509-520, 2021 | 84 | 2021 |
| Early lesion detection with 18F-DCFPyL PET/CT in 248 patients with biochemically recurrent prostate cancer M Wondergem, BHE Jansen, FM van der Zant, TM van der Sluis, RJJ Knol, ... European journal of nuclear medicine and molecular imaging 46, 1911-1918, 2019 | 71 | 2019 |
| Detection of recurrent prostate cancer using prostate-specific membrane antigen positron emission tomography in patients not meeting the Phoenix criteria for biochemical … BHE Jansen, PJ van Leeuwen, M Wondergem, TM Van der Sluis, ... European urology oncology 4 (5), 821-825, 2021 | 54 | 2021 |
| Non-invasive tumor genotyping using radiogenomic biomarkers, a systematic review and oncology-wide pathway analysis RW Jansen, P van Amstel, RM Martens, IE Kooi, P Wesseling, ... Oncotarget 9 (28), 20134, 2018 | 52 | 2018 |
| Simplified methods for quantification of 18F-DCFPyL uptake in patients with prostate cancer BHE Jansen, M Yaqub, J Voortman, MCF Cysouw, AD Windhorst, ... Journal of nuclear medicine 60 (12), 1730-1735, 2019 | 45 | 2019 |
| Detection of prostate cancer with 18F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible … YJL Bodar, BHE Jansen, JP Van Der Voorn, GJC Zwezerijnen, D Meijer, ... World journal of urology 39, 2439-2446, 2021 | 36 | 2021 |
| Repeatability of quantitative 18F-DCFPyL PET/CT measurements in metastatic prostate cancer BHE Jansen, MCF Cysouw, AN Vis, RJA van Moorselaar, J Voortman, ... Journal of Nuclear Medicine 61 (9), 1320-1325, 2020 | 33 | 2020 |
| Healthy tissue uptake of 68Ga-prostate-specific membrane antigen, 18F-DCFPyL, 18F-fluoromethylcholine, and 18F-dihydrotestosterone BHE Jansen, GM Kramer, MCF Cysouw, MM Yaqub, B de Keizer, ... Journal of Nuclear Medicine 60 (8), 1111-1117, 2019 | 33 | 2019 |
| Adding multiparametric MRI to the MSKCC and Partin nomograms for primary prostate cancer: Improving local tumor staging? BHE Jansen, JA Nieuwenhuijzen, DE Oprea-Lager, MJ Yska, AP Lont, ... Urologic Oncology: Seminars and Original Investigations 37 (3), 181. e1-181. e6, 2019 | 23 | 2019 |
| Prospective analysis of clinically significant prostate cancer detection with [18F]DCFPyL PET/MRI compared to multiparametric MRI: a comparison with the … YJL Bodar, BGJC Zwezerijnen, PJ van der Voorn, BHE Jansen, RS Smit, ... European journal of nuclear medicine and molecular imaging, 1-12, 2022 | 22 | 2022 |
| Local staging with multiparametric MRI in daily clinical practice: diagnostic accuracy and evaluation of a radiologic learning curve BHE Jansen, FHK Oudshoorn, AM Tijans, MJ Yska, AP Lont, ERP Collette, ... World journal of urology 36, 1409-1415, 2018 | 20 | 2018 |
| Letter to the Editor re: Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake MCF Cysouw, BHE Jansen, M Yaqub, J Voortman, AN Vis, ... Molecular Imaging and Biology 22, 15-17, 2020 | 13 | 2020 |
| Lesion detection and interobserver agreement with advanced image reconstruction for 18F-DCFPyL PET/CT in patients with biochemically recurrent prostate cancer BHE Jansen, RW Jansen, M Wondergem, S Srbljin, JMH de Klerk, ... Journal of Nuclear Medicine 61 (2), 210-216, 2020 | 13 | 2020 |
| What should junior doctors know about the drugs they frequently prescribe? A Delphi study among physicians in the Netherlands D Brinkman, G Disselhorst, B Jansen, J Tichelaar, M van Agtmael, ... Basic & clinical pharmacology & toxicology 118 (6), 456-461, 2016 | 11 | 2016 |
| Clinical verification of 18F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer D Meijer, BHE Jansen, M Wondergem, YJL Bodar, S Srbljin, ... Plos one 15 (10), e0239414, 2020 | 9 | 2020 |
| Essential diseases in prescribing: a national Delphi study towards a core curriculum in pharmacotherapy education BHE Jansen, GW Disselhorst, T Schutte, B Jansen, R Rissmann, ... British journal of clinical pharmacology 84 (11), 2645-2650, 2018 | 9 | 2018 |
| Preoperative multiparametric MRI does not lower positive surgical margin rate in a large series of patients undergoing robot-assisted radical prostatectomy L Gietelink, BHE Jansen, DE Oprea-Lager, JA Nieuwenhuijzen, AN Vis Journal of Robotic Surgery 16 (2), 273-278, 2022 | 8 | 2022 |
| Prostate specific membrane antigen positron emission tomography/computerized tomography in the evaluation of initial response in candidates who underwent salvage radiation … D Meijer, HB Luiting, PJ van Leeuwen, S Remmers, BHE Jansen, ... The Journal of Urology 205 (4), 1100-1109, 2021 | 7 | 2021 |
| Reply: Quantification of 18F-DCFPyL uptake: TBR versus Patlak’s analysis BHE Jansen, M Yaqub, MCF Cysouw, AN Vis, RJA van Moorselaar, ... Journal of Nuclear Medicine 60 (12), 1834-1835, 2019 | 3 | 2019 |
